Revance Therapeutics Leadership Changes
Effective October 1, 2025, Kira Schwartz joined as Chief Legal Officer, and Nick Crowe was promoted to Chief Operating Officer. This reshuffle aims to bolster legal and operational strategies amid market volatility.

Comments (0)
No comments yet. Be the first.